EHWM
Eads & Heald Wealth Management Portfolio holdings
AUM
$202M
This Quarter Return
+13.03%
1 Year Return
+18.55%
3 Year Return
+74.74%
5 Year Return
+137.36%
10 Year Return
+339.12%
AUM
$197M
AUM Growth
+$197M
(+12%)
Cap. Flow
-$344K
Cap. Flow
% of AUM
-0.17%
Top 10 Holdings %
Top 10 Hldgs %
15.03%
Holding
148
New
5
Increased
49
Reduced
78
Closed
3
Top Buys
| 1 |
Charles River Laboratories
CRL
|
$621K |
| 2 |
Crown Holdings
CCK
|
$392K |
| 3 |
BP
BP
|
$234K |
| 4 |
Bristol-Myers Squibb
BMY
|
$231K |
| 5 |
Prudential Financial
PRU
|
$221K |
Top Sells
| 1 |
Verisk Analytics
VRSK
|
$330K |
| 2 |
CBRE Group
CBRE
|
$313K |
| 3 |
Lam Research
LRCX
|
$239K |
| 4 |
Salesforce
CRM
|
$217K |
| 5 |
Cleveland-Cliffs
CLF
|
$199K |
Sector Composition
| 1 | Healthcare | 18.97% |
| 2 | Technology | 15.68% |
| 3 | Industrials | 15.57% |
| 4 | Consumer Staples | 14.39% |
| 5 | Consumer Discretionary | 12.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Medtronic
MDT
$120B
| $623K | 0.32% |
8,013
-1,770
| -18% | -$138K |
|
102
Advanced Micro Devices
AMD
$258B
| $622K | 0.32% |
9,601
-1,139
| -11% | -$73.8K |
|
|
103
Charles River Laboratories
CRL
$7.87B
| $621K | 0.32% |
+2,851
| New | +$621K |
|
104
Amcor
AMCR
$19.5B
| $619K | 0.31% |
51,964
-405
| -0.8% | -$4.82K |
|
105
PayPal
PYPL
$65.4B
| $595K | 0.3% |
8,356
-1,583
| -16% | -$113K |
|
106
Truist Financial
TFC
$59.1B
| $587K | 0.3% |
13,640
+1,062
| +8% | +$45.7K |
|
107
Freeport-McMoran
FCX
$63.7B
| $563K | 0.29% |
14,809
-1,400
| -9% | -$53.2K |
|
108
IBM
IBM
$223B
| $559K | 0.28% |
3,966
| – | – |
|
109
Autodesk
ADSK
$67.3B
| $532K | 0.27% |
2,848
-263
| -8% | -$49.1K |
|
110
Marsh & McLennan
MMC
$101B
| $526K | 0.27% |
3,180
| – | – |
|
111
Merck
MRK
$213B
| $497K | 0.25% |
4,482
+405
| +10% | +$44.9K |
|
112
Meta Platforms (Facebook)
META
$1.82T
| $475K | 0.24% |
3,943
-1,538
| -28% | -$185K |
|
|
113
CBRE Group
CBRE
$47.4B
| $474K | 0.24% |
6,155
-4,061
| -40% | -$313K |
|
114
Intel
INTC
$105B
| $464K | 0.24% |
17,570
-286
| -2% | -$7.55K |
|
115
Caterpillar
CAT
$194B
| $432K | 0.22% |
1,803
-56
| -3% | -$13.4K |
|
116
AT&T
T
$209B
| $431K | 0.22% |
23,432
+9,424
| +67% | +$173K |
|
117
Cigna
CI
$80.7B
| $428K | 0.22% |
1,292
+38
| +3% | +$12.6K |
|
118
McCormick & Company Non-Voting
MKC
$18.5B
| $426K | 0.22% |
5,140
| – | – |
|
119
PACCAR
PCAR
$51.6B
| $397K | 0.2% |
4,011
-35
| -0.9% | -$3.46K |
|
120
Pfizer
PFE
$141B
| $383K | 0.19% |
7,482
-140
| -2% | -$7.17K |
|
121
Morgan Stanley
MS
$235B
| $367K | 0.19% |
4,313
+120
| +3% | +$10.2K |
|
122
ITT
ITT
$13.1B
| $349K | 0.18% |
4,301
| – | – |
|
|
123
Salesforce
CRM
$238B
| $348K | 0.18% |
2,626
-1,637
| -38% | -$217K |
|
124
Citigroup
C
$172B
| $316K | 0.16% |
6,983
+605
| +9% | +$27.4K |
|
125
Mastercard
MA
$530B
| $316K | 0.16% |
910
-3
| -0.3% | -$1.04K |
|